HILPDA and lipid metabolism in colorectal cancer
HILPDA 与结直肠癌中的脂质代谢
基本信息
- 批准号:9000676
- 负责人:
- 金额:$ 7.7万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-02-01 至 2018-01-31
- 项目状态:已结题
- 来源:
- 关键词:APC geneAddressAdipocytesAllelesAnimal ModelAnimalsAntibodiesApcMin/+ miceAppearanceAreaAzoxymethaneBiochemicalBiological MarkersBiological ProcessBreedingCarcinogensCarcinomaCellsClinicalClinical ResearchColon CarcinomaColonic NeoplasmsColorectalColorectal CancerDataDefectDevelopmentDiseaseEpithelial CellsEtiologyEvolutionFibroblastsFirefly LuciferasesGene ExpressionGene ProteinsGenesGeneticGenetic ModelsGenetically Engineered MouseGerm-Line MutationGrowthHealthHumanHypoxiaIn VitroIncidenceInflammationInflammatoryInflammatory InfiltrateIntestinal NeoplasmsIntestinesInvestigationKRAS2 geneKnock-outLengthLesionLightLinkLipid BiochemistryLipid MobilizationLipidsLuc GeneMaintenanceMalignant - descriptorMalignant NeoplasmsMeasuresMetabolismMethodsModelingMorbidity - disease rateMouse ProteinMouse StrainsMusNatural HistoryNeoplasm MetastasisNormal tissue morphologyOncogenicOutcomePerfusionPhysiologicalPhysiologyPredispositionProductionPrognostic FactorProteinsReagentReporterResearchRoleSeveritiesSignal PathwaySignal TransductionSignaling MoleculeSodium Dextran SulfateSolid NeoplasmSpecimenStaining methodStainsStimulusStressStromal CellsStructureTP53 geneTertiary Protein StructureTestingTimeTissue MicroarrayTranscriptTumor Suppressor ProteinsTumor-DerivedVariantadenomaadipocyte differentiationcancer typecarcinogenesiscell typecolon carcinogenesisdata miningin vitro Modelin vivolipid biosynthesislipid metabolismloss of functionmortalitymouse modeloverexpressionperilipinprognostic significanceprogramsprotein expressionprotein functionresearch studyresponsetherapeutic targettooltumortumor growthtumor progressiontumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Colorectal cancer (CRC) is a major cause of morbidity and mortality and is the result of well characterized genetic aberrations. However, there are additional factors that modulate malignant progression and response to therapy. A large number of solid tumors contain areas of hypoxia as a result of defective tumor vasculature and poor perfusion. Hypoxia activates adaptive gene expression programs, regulating crucial biological processes including proliferation, metabolism, and metastasis. The presence of hypoxia and associated features is an adverse prognostic factor in a number of cancer types, and strategies are being developed to either overcome hypoxia or target hypoxic physiology therapeutically. Hypoxia-Inducible Lipid Droplet Associated Protein (HILPDA) is a stress-induced gene, encoding for a protein shown to localize to lipid droplets. HILPDA transcripts are highly expressed in CRC specimens but the protein's functional importance or its relation to other clinical parameters is not known. We have generated a genetically engineered mouse model where the HILPDA gene was disrupted and was replaced by the firefly Luciferase gene. This knockout/reporter mouse strain will be used to investigate colorectal oncogenesis. We hypothesize that HILPDA is a positive modulator of malignant progression by impacting colonic epithelial and stromal cell responses to oncogenic signals. Additionally, an in vitro model of adipogenesis will be used to identify HILPDA protein functional domains. We propose these investigations in 3 specific aims: 1) We will investigate the role of HILPDA in vivo in two murine models of CRC: a) in inflammation-associated carcinogenesis induced by treatment with Azoxymethane and Dextran Sodium Sulfate and b) in the context of APC inactivation by breeding the APC Min nonsense allele into our strain. Tumor incidence and multiplicity will be kinetically measured and the spectrum of lesions will be pathologically evaluated in both models. 2) Protein expression of HILPDA will be validated as a biomarker of more aggressive disease in human CRC specimens. 3) We will also identify HILPDA functional domains that can rescue the adipogenesis defects and deficiency of lipid droplets of KO cells in vitro. These HILPDA domains will then be functionally tested in transplantable tumors. These studies will determine the significance of HILPDA in CRC malignant progression and generate reagents for the mechanistic analysis of HILPDA function.
描述(由申请方提供):结直肠癌(CRC)是发病率和死亡率的主要原因,是充分表征的遗传畸变的结果。然而,还有其他因素可以调节恶性进展和对治疗的反应。由于肿瘤血管系统缺陷和灌注不良,大量实体瘤包含缺氧区域。缺氧激活适应性基因表达程序,调节重要的生物过程,包括增殖,代谢和转移。缺氧和相关特征的存在是许多癌症类型中的不良预后因素,并且正在开发策略以克服缺氧或治疗性靶向缺氧生理学。缺氧诱导脂滴相关蛋白(HILPDA)是一种应激诱导基因,编码一种定位于脂滴的蛋白质。HILPDA转录物在CRC标本中高度表达,但该蛋白质的功能重要性或其与其他临床参数的关系尚不清楚。我们已经产生了一种基因工程小鼠模型,其中HILPDA基因被破坏,并被萤火虫荧光素酶基因取代。该基因敲除/报告基因小鼠品系将用于研究结直肠肿瘤发生。我们假设HILPDA通过影响结肠上皮细胞和基质细胞对致癌信号的反应,是恶性进展的正调控因子。此外,将使用脂肪形成的体外模型来鉴定HILPDA蛋白质功能结构域。我们提出这些研究有3个具体目的:1)我们将研究HILPDA在两种CRC小鼠模型中的体内作用:a)在由氧化偶氮甲烷和葡聚糖硫酸钠治疗诱导的炎症相关的致癌作用中,和B)在通过将APC Min无义等位基因繁殖到我们的菌株中的APC失活的背景下。在两种模型中,将对肿瘤发生率和多样性进行动力学测量,并对病变谱进行病理学评价。2)HILPDA的蛋白表达将被验证为人类CRC标本中更具侵袭性疾病的生物标志物。3)我们还将鉴定可以在体外挽救KO细胞的脂肪形成缺陷和脂滴缺乏的HILPDA功能结构域。这些HILPDA结构域然后将在可移植肿瘤中进行功能测试。这些研究将确定HILPDA在CRC恶性进展中的意义,并产生用于HILPDA功能的机制分析的试剂。
项目成果
期刊论文数量(2)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Microenvironmental control of glucose metabolism in tumors by regulation of pyruvate dehydrogenase.
- DOI:10.1002/ijc.31812
- 发表时间:2019-02-15
- 期刊:
- 影响因子:6.4
- 作者:Golias T;Kery M;Radenkovic S;Papandreou I
- 通讯作者:Papandreou I
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Ioanna Papandreou其他文献
Ioanna Papandreou的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Ioanna Papandreou', 18)}}的其他基金
Metabolic modulation of alkylating agent efficacy in MEK inhibitor resistant thyroid cancers.
MEK 抑制剂耐药性甲状腺癌中烷化剂功效的代谢调节。
- 批准号:
10675021 - 财政年份:2022
- 资助金额:
$ 7.7万 - 项目类别:
Metabolic modulation of alkylating agent efficacy in MEK inhibitor resistant thyroid cancers.
MEK 抑制剂耐药性甲状腺癌中烷化剂功效的代谢调节。
- 批准号:
10512889 - 财政年份:2022
- 资助金额:
$ 7.7万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 7.7万 - 项目类别:
Research Grant